Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.

Ageing Alzheimer’s disease Birth cohort Cognition Epidemiology Genetics Life course Magnetic resonance imaging Positron emission tomography Vascular disease

Journal

BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555

Informations de publication

Date de publication:
23 Jan 2024
Historique:
received: 30 08 2023
accepted: 13 11 2023
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Although age is the biggest known risk factor for dementia, there remains uncertainty about other factors over the life course that contribute to a person's risk for cognitive decline later in life. Furthermore, the pathological processes leading to dementia are not fully understood. The main goals of Insight 46-a multi-phase longitudinal observational study-are to collect detailed cognitive, neurological, physical, cardiovascular, and sensory data; to combine those data with genetic and life-course information collected from the MRC National Survey of Health and Development (NSHD; 1946 British birth cohort); and thereby contribute to a better understanding of healthy ageing and dementia. Phase 1 of Insight 46 (2015-2018) involved the recruitment of 502 members of the NSHD (median age = 70.7 years; 49% female) and has been described in detail by Lane and Parker et al. 2017. The present paper describes phase 2 (2018-2021) and phase 3 (2021-ongoing). Of the 502 phase 1 study members who were invited to a phase 2 research visit, 413 were willing to return for a clinic visit in London and 29 participated in a remote research assessment due to COVID-19 restrictions. Phase 3 aims to recruit 250 study members who previously participated in both phases 1 and 2 of Insight 46 (providing a third data time point) and 500 additional members of the NSHD who have not previously participated in Insight 46. The NSHD is the oldest and longest continuously running British birth cohort. Members of the NSHD are now at a critical point in their lives for us to investigate successful ageing and key age-related brain morbidities. Data collected from Insight 46 have the potential to greatly contribute to and impact the field of healthy ageing and dementia by combining unique life course data with longitudinal multiparametric clinical, imaging, and biomarker measurements. Further protocol enhancements are planned, including in-home sleep measurements and the engagement of participants through remote online cognitive testing. Data collected are and will continue to be made available to the scientific community.

Sections du résumé

BACKGROUND BACKGROUND
Although age is the biggest known risk factor for dementia, there remains uncertainty about other factors over the life course that contribute to a person's risk for cognitive decline later in life. Furthermore, the pathological processes leading to dementia are not fully understood. The main goals of Insight 46-a multi-phase longitudinal observational study-are to collect detailed cognitive, neurological, physical, cardiovascular, and sensory data; to combine those data with genetic and life-course information collected from the MRC National Survey of Health and Development (NSHD; 1946 British birth cohort); and thereby contribute to a better understanding of healthy ageing and dementia.
METHODS/DESIGN METHODS
Phase 1 of Insight 46 (2015-2018) involved the recruitment of 502 members of the NSHD (median age = 70.7 years; 49% female) and has been described in detail by Lane and Parker et al. 2017. The present paper describes phase 2 (2018-2021) and phase 3 (2021-ongoing). Of the 502 phase 1 study members who were invited to a phase 2 research visit, 413 were willing to return for a clinic visit in London and 29 participated in a remote research assessment due to COVID-19 restrictions. Phase 3 aims to recruit 250 study members who previously participated in both phases 1 and 2 of Insight 46 (providing a third data time point) and 500 additional members of the NSHD who have not previously participated in Insight 46.
DISCUSSION CONCLUSIONS
The NSHD is the oldest and longest continuously running British birth cohort. Members of the NSHD are now at a critical point in their lives for us to investigate successful ageing and key age-related brain morbidities. Data collected from Insight 46 have the potential to greatly contribute to and impact the field of healthy ageing and dementia by combining unique life course data with longitudinal multiparametric clinical, imaging, and biomarker measurements. Further protocol enhancements are planned, including in-home sleep measurements and the engagement of participants through remote online cognitive testing. Data collected are and will continue to be made available to the scientific community.

Identifiants

pubmed: 38263061
doi: 10.1186/s12883-023-03465-3
pii: 10.1186/s12883-023-03465-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

40

Subventions

Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States
Organisme : Alzheimer's Association
ID : SG-666374-UK BIRTH COHORT PI Schott
Pays : United States

Informations de copyright

© 2024. The Author(s).

Références

Hersi M, Irvine B, Gupta P, Gomes J, Birkett N, Krewski D. Risk factors associated with the onset and progression of Alzheimer’s disease: A systematic review of the evidence. Neurotoxicology. 2017;61:143–87.
pubmed: 28363508 doi: 10.1016/j.neuro.2017.03.006
Serrano-Pozo A, Growdon JH. Is Alzheimer’s Disease Risk Modifiable? J Alzheimer’s dis. 2019;67(3):795–819.
doi: 10.3233/JAD181028
Parnetti L, Chipi E, Salvadori N, D’Andrea K, Eusebi P. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis. Alzheimers Res Ther. 2019;11(1):7.
pubmed: 30646955 pmcid: 6334406 doi: 10.1186/s13195-018-0459-7
Statistics OfN. Death registration summary statistics, England and Wales: 2022. Number of deaths registered by year, sex, area of unusutal residence and selected underlying cause of death. 2023.
NHS. About Dementia [updated 25 June 2021. Available from: https://www.nhs.uk/conditions/dementia/about/ .
Centre TLSoEaPSCPaE. Projections of older people with dementia and costs of dementia care in the United Kingdon, 2019–2040. 2019.
Velandia PP, Miller-Petrie MK, Chen C, Chakrabarti S, Chapin A, Hay S, et al. Global and regional spending on dementia care from 2000–2019 and expected future health spending scenarios from 2020–2050: An economic modelling exercise. Eclinicalmedicine. 2022;45: 101337.
pubmed: 35299657 pmcid: 8921543 doi: 10.1016/j.eclinm.2022.101337
Breijyeh Z, Karaman R. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment. Molecules. 2020;25(24):5789.
Khan A, Kalaria RN, Corbett A, Ballard C. Update on Vascular Dementia. J Geriatr Psychiatry Neurol. 2016;29(5):281–301.
pubmed: 27502303 doi: 10.1177/0891988716654987
Lane CA, Parker TD, Cash DM, Macpherson K, Donnachie E, Murray-Smith H, et al. Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development. BMC Neurol. 2017;17(1):75.
pubmed: 28420323 pmcid: 5395844 doi: 10.1186/s12883-017-0846-x
Kuh D, Pierce M, Adams J, Deanfield J, Ekelund U, Friberg P, et al. Cohort profile: updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research. Int J Epidemiol. 2011;40(1):e1–9.
pubmed: 21345808 pmcid: 3043283 doi: 10.1093/ije/dyq231
Kuh D, Wong A, Shah I, Moore A, Popham M, Curran P, et al. The MRC National Survey of Health and Development reaches age 70: maintaining participation at older ages in a birth cohort study. Eur J Epidemiol. 2016;31(11):1135–47.
pubmed: 27995394 pmcid: 5206260 doi: 10.1007/s10654-016-0217-8
Mason SA, Al Saikhan L, Jones S, Bale G, James SN, Murray-Smith H, et al. Study Protocol - Insight 46 Cardiovascular: A Sub-study of the MRC National Survey of Health and Development. Artery Res. 2020;26(3):170–9.
pubmed: 32879639 pmcid: 7116008 doi: 10.2991/artres.k.200417.001
James SN, Lane CA, Parker TD, Lu K, Collins JD, Murray-Smith H, et al. Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46. BMC Res Notes. 2018;11(1):885.
pubmed: 30545411 pmcid: 6293512 doi: 10.1186/s13104-018-3995-0
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, et al. Prevalence of cerebral amyloid pathology in persons without dementia a meta-analysis. Jama-J Am Med Assoc. 2015;313(19):1924–38.
doi: 10.1001/jama.2015.4668
Keshavan A, Pannee J, Karikari TK, Rodriguez JL, Ashton NJ, Nicholas JM, et al. Population-based blood screening for preclinical Alzheimer’s disease in a British birth cohort at age 70. Brain. 2021;144(2):434–49.
pubmed: 33479777 pmcid: 7940173
Keuss SE, Coath W, Nicholas JM, Poole T, Barnes J, Cash DM, et al. Associations of β-Amyloid and Vascular Burden With Rates of Neurodegeneration in Cognitively Normal Members of the 1946 British Birth Cohort. Neurology. 2022;99(2):e129–41.
pubmed: 35410910 pmcid: 9280996 doi: 10.1212/WNL.0000000000200524
Lu K, Nicholas JM, Collins JD, James SN, Parker TD, Lane CA, et al. Cognition at age 70: Life course predictors and associations with brain pathologies. Neurology. 2019;93(23):e2144–56.
Lu K, Nicholas JM, James SN, Lane CA, Parker TD, Keshavan A, et al. Increased variability in reaction time is associated with amyloid beta pathology at age 70. Alzheimers Dement (Amst). 2020;12(1): e12076.
pubmed: 32789161
Parker TD, Cash DM, Lane CA, Lu K, Malone IB, Nicholas JM, et al. Amyloid beta influences the relationship between cortical thickness and vascular load. Alzheimers Dement (Amst). 2020;12(1): e12022.
pubmed: 32313829
Papp KV, Amariglio RE, Dekhtyar M, Roy K, Wigman S, Bamfo R, et al. Development of a Psychometrically Equivalent Short Form of the Face-Name Associative Memory Exam for use Along the Early Alzheimer’s Disease Trajectory. Clinical Neuropsychologist. 2014;28(5):771–85.
pubmed: 24815535 doi: 10.1080/13854046.2014.911351
Davis D, Bendayan R, Muniz Terrera G, Hardy R, Richards M, Kuh D. Decline in Search Speed and Verbal Memory Over 26 Years of Midlife in a British Birth Cohort. Neuroepidemiology. 2017;49(3–4):121–8.
pubmed: 29145205 doi: 10.1159/000481136
Weston PSJ, Nicholas JM, Henley SMD, Liang Y, Macpherson K, Donnachie E, et al. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer’s disease: a cross-sectional study. Lancet Neurol. 2018;17(2):123–32.
pubmed: 29413314 pmcid: 5958413 doi: 10.1016/S1474-4422(17)30434-9
McKenna P, Warrington EK. Testing for nominal dysphasia. J Neurol Neurosurg Psychiatry. 1980;43(9):781–8.
pubmed: 7420102 pmcid: 490668 doi: 10.1136/jnnp.43.9.781
Mengoudi K, Ravi D, Yong KXX, Primativo S, Pavisic IM, Brotherhood E, et al. Augmenting Dementia Cognitive Assessment With Instruction-Less Eye-Tracking Tests. IEEE J Biomed Health Inform. 2020;24(11):3066–75.
pubmed: 32749977 doi: 10.1109/JBHI.2020.3004686
Lu K, Nicholas JM, Pertzov Y, Grogan J, Husain M, Pavisic IM, et al. Dissociable effects of APOE ε4 and β-amyloid pathology on visual working memory. Nature Aging. 2021;1(11):1002–9.
pubmed: 34806027 pmcid: 7612005 doi: 10.1038/s43587-021-00117-4
Lu K, Nicholas JM, Weston PSJ, Stout JC, O'Regan AM, James SN, et al. Visuomotor integration deficits are common to familial and sporadic preclinical Alzheimer's disease. Brain Commun. 2021;3(1):fcab003.
Wechsler D. WMS-R: Wechsler Memory Scale-Revised: Manual. San Antonio, TX: Psychological Corporation; 1987.
Binaco R, Calzaretto N, Epifano J, McGuire S, Umer M, Emrani S, et al. Machine learning analysis of digital clock drawing test performance for differential classification of mild cognitive impairment subtypes versus Alzheimer’s Disease. J Int Neuropsych Soc. 2020;26(7):690–700.
doi: 10.1017/S1355617720000144
Petti U, Baker S, Korhonen A. A systematic literature review of automatic Alzheimer’s disease detection from speech and language. J Am Med Inform Assoc. 2020;27(11):1784–97.
pubmed: 32929494 pmcid: 7671617 doi: 10.1093/jamia/ocaa174
Galvin JE, Roe CM, Powlishta KK, Coats MA, Muich SJ, Grant E, et al. The AD8: a brief informant interview to detect dementia. Neurology. 2005;65(4):559–64.
pubmed: 16116116 doi: 10.1212/01.wnl.0000172958.95282.2a
Galvin JE, Roe CM, Xiong C, Morris JC. Validity and reliability of the AD8 informant interview in dementia. Neurology. 2006;67(11):1942–8.
pubmed: 17159098 doi: 10.1212/01.wnl.0000247042.15547.eb
Pavisic IM, Lu K, Keuss SE, James SN, Lane CA, Parker TD, et al. Subjective cognitive complaints at age 70: associations with amyloid and mental health. J Neurol Neurosurg Psychiatry. 2021;92(11):1215–21.
Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry. 1982;140:566–72.
pubmed: 7104545 doi: 10.1192/bjp.140.6.566
Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412–4.
pubmed: 8232972 doi: 10.1212/WNL.43.11.2412-a
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189–98.
Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Malone IB, et al. Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort. JAMA Neurol. 2019;77(2):175–83.
Lane CA, Barnes J, Nicholas JM, Sudre CH, Cash DM, Parker TD, et al. Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort (Insight 46): an epidemiological study. Lancet Neurol. 2019;18(10):942–52.
pubmed: 31444142 pmcid: 6744368 doi: 10.1016/S1474-4422(19)30228-5
Kuh D, Bassey EJ, Butterworth S, Hardy R, Wadsworth ME. Musculoskeletal Study T. Grip strength, postural control, and functional leg power in a representative cohort of British men and women: associations with physical activity, health status, and socioeconomic conditions. J Gerontol A Biol Sci Med Sci. 2005;60(2):224–31.
pubmed: 15814867 doi: 10.1093/gerona/60.2.224
Pavlova AV, Muthuri SG, Cooper R, Saunders FR, Gregory JS, Barr RJ, et al. Body mass index and waist circumference in early adulthood are associated with thoracolumbar spine shape at age 60–64: The Medical Research Council National Survey of Health and Development. PLoS ONE. 2018;13(6): e0197570.
pubmed: 29902185 pmcid: 6002244 doi: 10.1371/journal.pone.0197570
Jones S, Tillin T, Williams S, Coady E, Chaturvedi N, Hughes AD. Assessment of Exercise Capacity and Oxygen Consumption Using a 6 min Stepper Test in Older Adults. Front Physiol. 2017;8:408.
pubmed: 28659823 pmcid: 5469915
Dercon Q, Nicholas JM, James SN, Schott JM, Richards M. Grip strength from midlife as an indicator of later-life brain health and cognition: evidence from a British birth cohort. BMC Geriatr. 2021;21(1):475.
pubmed: 34465287 pmcid: 8406895 doi: 10.1186/s12877-021-02411-7
Hardy R, Cooper R, Shah I, Harridge S, Guralnik J, Kuh D. Is chair rise performance a useful measure of leg power? Aging Clin Exp Res. 2010;22(5–6):412–8.
pubmed: 21422795 pmcid: 3260651 doi: 10.1007/BF03324942
Blodgett JM, Kuh D, Hardy R, Davis DHJ, Cooper R. Childhood cognition and age-related change in standing balance performance from mid to later life: findings from a british birth cohort. J Gerontol A Biol Sci Med Sci. 2020;75(1):155–61.
pubmed: 30535263 doi: 10.1093/gerona/gly275
Cai Y, Shaheen SO, Hardy R, Kuh D, Hansell AL. Birth weight, early childhood growth and lung function in middle to early old age: 1946 British birth cohort. Thorax. 2016;71(10):916–22.
pubmed: 26185199 doi: 10.1136/thoraxjnl-2014-206457
Orfei L, Strachan DP, Rudnicka AR, Wadsworth ME. Early influences on adult lung function in two national British cohorts. Arch Dis Child. 2008;93(7):570–4.
pubmed: 17626144 doi: 10.1136/adc.2006.112201
Leelarathna L, Wilmot EG. Flash forward: a review of flash glucose monitoring. Diabet Med. 2018;35(4):472–82.
pubmed: 29356072 doi: 10.1111/dme.13584
Parker T, Cash DM, Lane C, Lu K, Malone IB, Nicholas JM, et al. Pure tone audiometry and cerebral pathology in healthy older adults. J Neurol Neurosurg Psychiatry. 2020;91(2):172–76.
Buchanan SM, Parker TD, Lane CA, Keshavan A, Keuss SE, Lu K, et al. Olfactory testing does not predict beta-amyloid, MRI measures of neurodegeneration or vascular pathology in the British 1946 birth cohort. J Neurol. 2020;267(11):3329–36.
pubmed: 32583050 pmcid: 7311798 doi: 10.1007/s00415-020-10004-4
Piqueras-Fiszman B, Laughlin Z, Miodownik M, Spence C. Tasting spoons: Assessing how the material of a spoon affects the taste of the food. Food Qual Prefer. 2012;24(1):24–9.
doi: 10.1016/j.foodqual.2011.08.005
Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.
pubmed: 1798888 doi: 10.1093/sleep/14.6.540
Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15(4):376–81.
pubmed: 1519015 doi: 10.1093/sleep/15.4.376
Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.
pubmed: 2748771 doi: 10.1016/0165-1781(89)90047-4
Stiasny-Kolster K, Mayer G, Schafer S, Moller JC, Heinzel-Gutenbrunner M, Oertel WH. The REM sleep behavior disorder screening questionnaire–a new diagnostic instrument. Movement Disord. 2007;22(16):2386–93.
pubmed: 17894337 doi: 10.1002/mds.21740
Ehring T, Zetsche U, Weidacker K, Wahl K, Schonfeld S, Ehlers A. The Perseverative Thinking Questionnaire (PTQ): validation of a content-independent measure of repetitive negative thinking. J Behav Ther Exp Psychiatry. 2011;42(2):225–32.
pubmed: 21315886 pmcid: 3042595 doi: 10.1016/j.jbtep.2010.12.003
James SN, Nicholas JM, Lane CA, Parker TD, Lu K, Keshavan A, et al. A population-based study of head injury, cognitive function and pathological markers. Ann Clin Transl Neurol. 2021;8(4):842–56.
pubmed: 33694298 pmcid: 8045921 doi: 10.1002/acn3.51331
Bridges KW, Goldberg DP. The validation of the GHQ-28 and the use of the MMSE in neurological in-patients. Br J Psychiatry. 1986;148:548–53.
pubmed: 3779225 doi: 10.1192/bjp.148.5.548
Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979;9(1):139–45.
pubmed: 424481 doi: 10.1017/S0033291700021644
Keuss SE, Parker TD, Lane CA, Hoskote C, Shah S, Cash DM, et al. Incidental findings on brain imaging and blood tests: results from the first phase of Insight 46, a prospective observational substudy of the 1946 British birth cohort. BMJ Open. 2019;9(7): e029502.
pubmed: 31371298 pmcid: 6678011 doi: 10.1136/bmjopen-2019-029502
Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89.
Cao L, McDonnell A, Nitzsche A, Alexandrou A, Saintot PP, Loucif AJ, et al. Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia. Sci Transl Med. 2016;8(335):335ra56.
Keshavan A, Wellington H, Chen Z, Khatun A, Chapman M, Hart M, et al. Concordance of CSF measures of Alzheimer’s pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays. Alzheimers Dement (Amst). 2020;12(1): e12097.
pubmed: 32999915
Parker TD, Cash DM, Lane CAS, Lu K, Malone IB, Nicholas JM, et al. Hippocampal subfield volumes and pre-clinical Alzheimer’s disease in 408 cognitively normal adults born in 1946. PLoS ONE. 2019;14(10): e0224030.
pubmed: 31622410 pmcid: 6797197 doi: 10.1371/journal.pone.0224030
Parker TD, Cash DM, Lane CA, Lu K, Malone IB, Nicholas JM, et al. Amyloid β influences the relationship between cortical thickness and vascular load. Alzheimers Dement (Amst). 2020;12(1): e12022.
pubmed: 32313829
Richards M, Sacker A. Lifetime antecedents of cognitive reserve. J Clin Exp Neuropsyc. 2003;25(5):614–24.
doi: 10.1076/jcen.25.5.614.14581
James SN, Davis D, O’Hare C, Sharma N, John A, Gaysina D, et al. Lifetime affective problems and later-life cognitive state: Over 50 years of follow-up in a British birth cohort study. J Affect Disord. 2018;241:348–55.
pubmed: 30144717 pmcid: 6137547 doi: 10.1016/j.jad.2018.07.078
Rawle MJ, Davis D, Bendayan R, Wong A, Kuh D, Richards M. Apolipoprotein-E (Apoe) epsilon4 and cognitive decline over the adult life course. Transl Psychiatry. 2018;8(1):18.
pubmed: 29317609 pmcid: 5802532 doi: 10.1038/s41398-017-0064-8
Coughlin AKH, S.E. The adult memory and information processing battery (AMIPB): test manual: A.K. Coughlin, Psychology Dept, St James' Hospital, Leeds; 1985.
Huckvale MAB, D.M.; Dworkin, M.W.; Johnson, M.E.; Pearce, D.J.; Whitaker, L., editor The SPAR speech filing system. European Conference on Speech Technology; 1987; Edinburgh.
Primativo S, Clark C, Yong KXX, Firth NC, Nicholas J, Alexander D, et al. Eyetracking metrics reveal impaired spatial anticipation in behavioural variant frontotemporal dementia. Neuropsychologia. 2017;106:328–40.
pubmed: 29031740 doi: 10.1016/j.neuropsychologia.2017.10.014
Weston PSJ, Nicholas JM, Henley SMD. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study (vol 17, pg 123, 2018). Lancet Neurology. 2018;17(4):298.
Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0–10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26(3):216–22.
pubmed: 10839848 doi: 10.1016/S0099-1767(00)90093-X
Parker T, Cash DM, Lane C, Lu K, Malone IB, Nicholas JM, et al. Pure tone audiometry and cerebral pathology in healthy older adults. J Neurol Neurosurg Psychiatry. 2020;91(2):172–6.
pubmed: 31699832 doi: 10.1136/jnnp-2019-321897
Hatch SL, Jones PB, Kuh D, Hardy R, Wadsworth ME, Richards M. Childhood cognitive ability and adult mental health in the British 1946 birth cohort. Social science & medicine (1982). 2007;64(11):2285–96.
Ploubidis G, Abbott R, Huppert F, Kuh D, Wadsworth M, Croudace T. Improvements in social functioning reported by a birth cohort in mid-adult life: A person-centred analysis of GHQ-28 social dysfunction items using latent class analysis. Personality Individ Differ. 2007;42:305–16.
doi: 10.1016/j.paid.2006.07.010
Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, Gruetter R. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage. 2010;49(2):1271–81.
pubmed: 19819338 doi: 10.1016/j.neuroimage.2009.10.002
Woods JG, Chappell MA, Okell TW. Designing and comparing optimized pseudo-continuous Arterial Spin Labeling protocols for measurement of cerebral blood flow. Neuroimage. 2020;223:117246.
Wong SM, Backes WH, Zhang CE, Staals J, van Oostenbrugge RJ, Jeukens C, et al. On the Reproducibility of Inversion Recovery Intravoxel Incoherent Motion Imaging in Cerebrovascular Disease. AJNR Am J Neuroradiol. 2018;39(2):226–31.
pubmed: 29217741 pmcid: 7410585 doi: 10.3174/ajnr.A5474
Heeman F, Yaqub M, Lopes Alves I, Heurling K, Berkhof J, Gispert JD, et al. Optimized dual-time-window protocols for quantitative [(18)F]flutemetamol and [(18)F]florbetaben PET studies. EJNMMI Res. 2019;9(1):32.
pubmed: 30919133 pmcid: 6437225 doi: 10.1186/s13550-019-0499-4
Kuh D, Wills AK, Shah I, Prentice A, Hardy R, Adams JE, et al. Growth from birth to adulthood and bone phenotype in early old age: a British birth cohort study. J Bone Miner Res. 2014;29(1):123–33.
pubmed: 23761289 doi: 10.1002/jbmr.2008
Medical Research Council TWT. Framework on the feedback of health-related findings in research. 2014.
Kuh D, Muthuri SG, Moore A, Cole TJ, Adams JE, Cooper C, et al. Pubertal timing and bone phenotype in early old age: findings from a British birth cohort study. Int J Epidemiol. 2016;45(4):1113–24.
pubmed: 27401728 pmcid: 5075580
Wolf SM, Lawrenz FP, Nelson CA, Kahn JP, Cho MK, Clayton EW, et al. Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics. 2008;36(2):219–48, 1.
Webber M, Falconer D, AlFarih M, Joy G, Chan F, Davie C, et al. Study protocol: MyoFit46-the cardiac sub-study of the MRC National Survey of Health and Development. BMC Cardiovasc Disord. 2022;22(1):140.
pubmed: 35365075 pmcid: 8972905 doi: 10.1186/s12872-022-02582-0
Wagen AZ, Coath W, Keshavan A, James SN, Parker TD, Lane CA, et al. Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study. Lancet Healthy Longev. 2022;3(9):e607–16.
pubmed: 36102775 pmcid: 10499760 doi: 10.1016/S2666-7568(22)00167-2
Hampshire A, Trender W, Chamberlain SR, Jolly AE, Grant JE, Patrick F, et al. Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine. 2021;39:101044.
Usher I, Hellyer P, Lee KS, Leech R, Hampshire A, Alamri A, et al. "It's not rocket science" and "It's not brain surgery"-"It's a walk in the park": prospective comparative study. BMJ. 2021;375:e067883.

Auteurs

Heidi Murray-Smith (H)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK. h.murray-smith@ucl.ac.uk.

Suzie Barker (S)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Frederik Barkhof (F)

Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Centre for Medical Image Computing, University College London, London, UK.
Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Josephine Barnes (J)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Thomas M Brown (TM)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Gabriella Captur (G)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Molly R E Cartlidge (M)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

David M Cash (DM)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Centre for Medical Image Computing, University College London, London, UK.

William Coath (W)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Daniel Davis (D)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

John C Dickson (JC)

Institute of Nuclear Medicine, University College London Hospitals, London, UK.

James Groves (J)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Alun D Hughes (AD)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Sarah-Naomi James (SN)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Ashvini Keshavan (A)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Sarah E Keuss (SE)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Josh King-Robson (J)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Kirsty Lu (K)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Ian B Malone (IB)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Jennifer M Nicholas (JM)

Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.

Alicja Rapala (A)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Catherine J Scott (CJ)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Institute of Nuclear Medicine, University College London Hospitals, London, UK.

Rebecca Street (R)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Carole H Sudre (CH)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Centre for Medical Image Computing, University College London, London, UK.
MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

David L Thomas (DL)

Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.

Andrew Wong (A)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Selina Wray (S)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Henrik Zetterberg (H)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
UK Dementia Research Institute, University College London, London, UK.
Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.
Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Hong, Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.
Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.

Nishi Chaturvedi (N)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Nick C Fox (NC)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Sebastian J Crutch (SJ)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Marcus Richards (M)

MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.

Jonathan M Schott (JM)

Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.

Classifications MeSH